Analysts expect Lipella Pharmaceuticals Inc. to report revenue of 84,428.00 for Q3 24, against a range of 77,700.27 to 91,155.73. The most recent reported quarter, Q2 25, came in at 86,727.00, a 24.1% miss against the 114,251.82 consensus.
| Metric | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 121,000.00 | 146,000.00 | 136,000.00 | - | - | - | 86,727.00 | - | - | - | - | - | |||||||||||||||||
| High Estimate | - | 151,483.23 | 151,922.24 | 91,155.73 | 105,191.00 | 120,696.18 | 123,783.96 | 68,672.42 | 64,893.95 | 87,262.77 | 79,206.95 | 44,711.40 | |||||||||||||||||
| Low Estimate | - | 124,948.79 | 128,607.68 | 77,700.27 | 98,840.12 | 98,777.96 | 104,719.68 | 63,517.66 | 59,264.95 | 75,377.35 | 70,806.49 | 38,884.98 | |||||||||||||||||
| Consensus Estimate | - | 138,216.01 | 140,264.96 | 84,428.00 | 102,015.56 | 109,737.07 | 114,251.82 | 66,095.04 | 62,079.45 | 81,320.06 | 75,006.72 | 41,798.19 |
Analysts expect Lipella Pharmaceuticals Inc. to report earnings per share of -11.01 for Q3 24, against a range of -11.99 to -10.03. The most recent reported quarter, Q3 25, came in at -0.28, a 96.5% beat against the -7.91 consensus.
| Metric | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.80 | -1.28 | -0.99 | - | - | - | -0.31 | -0.28 | - | - | - | - | - | ||||||||||||||||
| High Estimate | - | -1.32 | -0.93 | -10.03 | -2.36 | 0.87 | 1.62 | -7.45 | -0.02 | -1.71 | -1.61 | -11.00 | -2.64 | ||||||||||||||||
| Low Estimate | - | -1.40 | -1.13 | -11.99 | -2.62 | 0.71 | 1.48 | -8.37 | -0.02 | -1.95 | -1.95 | -12.06 | -2.86 | ||||||||||||||||
| Consensus Estimate | - | -1.36 | -1.03 | -11.01 | -2.49 | 0.79 | 1.55 | -7.91 | -0.02 | -1.83 | -1.78 | -11.53 | -2.75 |
Pull Wall Street consensus for Lipella Pharmaceuticals Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=LIPO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "LIPO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=LIPO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();